Moleculin Biotech at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Moleculin Biotech at ASH 2026 in New Orleans: Booth 249.
| Organization | ASH 2026 Attendance |
|---|---|
Moleculin Biotech Houston, TX | |
Clinical-stage drug developer whose lead program, annamycin, is a next-generation anthracycline built to limit drug resistance and heart toxicity. | Booth Exhibiting at Booth 249 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm |
Find decision makers at Moleculin Biotech
Tell us what you sell and we’ll find the people at Moleculin Biotech most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction